Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes
Authors
Keywords
Anti-VEGF, Bevacizumab, Choroidal neovascularization, Intravitreal, Long-term, Pathological myopia
Journal
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Volume 254, Issue 3, Pages 445-454
Publisher
Springer Nature
Online
2015-06-17
DOI
10.1007/s00417-015-3076-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization
- (2015) Yasushi Ikuno et al. OPHTHALMOLOGY
- Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review
- (2013) Tien Y. Wong et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcome
- (2013) Jose M Ruiz-Moreno et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results
- (2013) Enrico Peiretti et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study
- (2013) Adnan Tufail et al. OPHTHALMOLOGY
- RADIANCE: A Randomized Controlled Study of Ranibizumab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia
- (2013) Sebastian Wolf et al. OPHTHALMOLOGY
- Long-term results of intravitreal bevacizumab for choroidal neovascularisation in pathological myopia
- (2012) Magda Gharbiya et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization
- (2012) T Y Y Lai et al. EYE
- Factors associated with enlargement of chorioretinal atrophy after intravitreal bevacizumab for myopic choroidal neovascularization
- (2012) Riyo Uemoto et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization
- (2012) Akio Oishi et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- COMPARISON OF COLOR FUNDUS PHOTOGRAPHS AND FUNDUS AUTOFLUORESCENCE IMAGES IN MEASURING GEOGRAPHIC ATROPHY AREA
- (2012) Aziz A. Khanifar et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses
- (2011) Jose M. Ruiz-Moreno et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Long-Term Follow-Up of Myopic Choroidal Neovascularization Treated with Ranibizumab
- (2011) Nuno Franqueira et al. OPHTHALMOLOGICA
- INTRAVITREAL BEVACIZUMAB THERAPY ON AN AS-PER-NEEDED BASIS IN SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGICAL MYOPIA
- (2011) Pierluigi Iacono et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Choroidal Neovascularization in Pathologic Myopia: Intravitreal Ranibizumab Versus Bevacizumab—A Randomized Controlled Trial
- (2010) Magda Gharbiya et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome
- (2010) Jose M. Ruiz-Moreno et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2010) RUFINO M. SILVA et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Central Retinal Sensitivity After Intravitreal Injection of Bevacizumab for Myopic Choroidal Neovascularization
- (2009) Yuko Yodoi et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Two-Year Visual Results for Older Asian Women Treated With Photodynamic Therapy or Bevacizumab for Myopic Choroidal Neovascularization
- (2009) Yasushi Ikuno et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation
- (2009) T. Baba et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results
- (2009) J M Monés et al. EYE
- Intravitreal Bevacizumab Treatment for Choroidal Neovascularization in Pathologic Myopia: 12-month Results
- (2008) Magda Gharbiya et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation